Human Papillomavirus Vaccine Awareness, Acceptability, and Decision-Making Factors among Chinese College Students |
Wang, Shao-Ming
(Cancer Institute/ Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College)
Zhang, Shao-Kai (Cancer Institute/ Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College) Pan, Xiong-Fei (Cancer Institute/ Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College) Ren, Ze-Fang (Department of Epidemiology and Biostatistics, School of Public Health, Sun Yat-sen University) Yang, Chun-Xia (Department of Epidemiology, West China School of Public Health, Sichuan University) Wang, Zeng-Zhen (Department of Epidemiology and Health Statistics, School of Public Health, Tongji Medical College of Huazhong University of Science and Technology) Gao, Xiao-Hong (Department of Epidemiology, School of Public Health, Dalian Medical University) Li, Man (School of Public Health, Capital Medical University) Zheng, Quan-Qing (Department of Public Health, Medical School of Xi'an Jiaotong University) Ma, Wei (Department of Epidemiology and Health Statistics, School of Public Health, Shandong University) Zhao, Fang-Hui (Cancer Institute/ Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College) Qiao, You-Lin (Cancer Institute/ Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College) Sivasubramaniam, Priya (Cancer Institute/ Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College) |
1 | Li J, Li LK, Ma JF, et al (2009). Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine, 27, 1210-5. DOI ScienceOn |
2 | Li R, Li Y, Radley D, et al (2012). Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females. Vaccine, 30, 4284-91. DOI |
3 | Liddon N, Hood J, Wynn BA, et al (2010). Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health, 46, 113-23. DOI ScienceOn |
4 | Lindley LL, Elkind JS, Landi SN, et al (2013). Receipt of the human papillomavirus vaccine among female college students in the United States, 2009. J Am Coll Health, 61, 18-27. DOI |
5 | Allen JD, Fantasia HC, Fontenot H, et al (2009). College men's knowledge, attitudes, and beliefs about the human papillomavirus infection and vaccine. J Adolesc Health, 45, 535-7. DOI |
6 | Canfell K, Shi JF, Lew JB, et al (2011). Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29, 2487-94. DOI |
7 | Ferlay J SI, Ervik M, Dikshit R, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. |
8 | Garland SM, Hernandez-Avila M, Wheeler CM, et al (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med, 356, 1928-43. DOI ScienceOn |
9 | Makwe CC, Anorlu RI, Odeyemi KA (2012). Human papillomavirus (HPV) infection and vaccines: knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. J Epidemiol Glob Health, 2, 199-206. DOI |
10 | Marek E, Dergez T, Kricskovics A, et al (2011). Difficulties in the prevention of cervical cancer: adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary. Vaccine, 29, 5122-9. DOI |
11 | Markowitz LE, Tsu V, Deeks SL, et al (2012). Human papillomavirus vaccine introduction-the first five years. Vaccine, 30, 139-48. DOI |
12 | Wang SM, Qiao YL (2010). Perspective of implementation of prophylactic HPV vaccine in China, Oncology Progress, 3, 134-8. |
13 | WHO (2009). Human papillomavirus vaccines: WHO position paper. Biologicals, 37, 338-44. DOI |
14 | Katz ML, Krieger JL, Roberto AJ (2011). Human papillomavirus (HPV): college male's knowledge, perceived risk, sources of information, vaccine barriers and communication. J Mens health, 8, 175-84. DOI ScienceOn |
15 | Zhang SK, Pan XF, Wang SM, et al (2013). Perceptions and acceptability of HPV vaccination among parents of young adolescents: A multicenter national survey in China. Vaccine, 31, 3244-9. DOI ScienceOn |
16 | Zhao FH, Tiggelaar SM, Hu SY, et al (2012a). A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol, 36, 384-90. DOI |
17 | Zhao FH, Tiggelaar SM, Hu SY, et al (2012b). A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78. 과학기술학회마을 DOI ScienceOn |
18 | Harper DM (2008). Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age. Gynecol Oncol, 110, 11-7. |
19 | Jones M, Cook R (2008). Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health, 57, 23-32. DOI |
20 | Kang HS, Moneyham L (2009). Attitudes toward and intention to receive the human papilloma virus (HPV) vaccination and intention to use condoms among female Korean college students. Vaccine, 28, 811-6. |
21 | Kreimer AR, Rodriguez AC, Hildesheim A, et al (2011). Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst, 103, 1444-51. DOI |